NUSS; John
Patent Applications and Registrations
Patent applications and USPTO patent grants for NUSS; John.The latest application filed is for "nlrp3 modulators".
- NUSS; John - Encinitas CA
- NUSS; John - San Diego CA
- Nuss; John - Carlsbad CA
- Nuss; John - Danville CA US
| Patent | Date |
|---|---|
| Nlrp3 Modulators App 20220259170 - MOHAN; Raju ; et al. | 2022-08-18 |
| Heterocyclic Compounds For The Treatment Of Disease App 20220227767 - MOHAN; Raju ; et al. | 2022-07-21 |
| Ror-gamma Modulators App 20220175765 - MOHAN; Raju ; et al. | 2022-06-09 |
| Tyk2 Pseudokinase Ligands App 20220169651 - MOHAN; Raju ; et al. | 2022-06-02 |
| Tyk2 Pseudokinase Ligands App 20220135567 - MOHAN; Raju ; et al. | 2022-05-05 |
| Bicyclic Ror-gamma Modulators App 20220106329 - MOHAN; Raju ; et al. | 2022-04-07 |
| Spirocyclic Ror-gamma Modulators App 20220106323 - MOHAN; Raju ; et al. | 2022-04-07 |
| Spirocyclic ROR-gamma modulators Grant 11,242,350 - Mohan , et al. February 8, 2 | 2022-02-08 |
| Bicyclic ROR.gamma. modulators Grant 11,230,555 - Mohan , et al. January 25, 2 | 2022-01-25 |
| JAK inhibitors Grant 11,136,329 - Mohan , et al. October 5, 2 | 2021-10-05 |
| Nlrp3 Modulators App 20210292336 - MOHAN; Raju ; et al. | 2021-09-23 |
| Heterocyclic Compounds for the Treatment of Disease App 20210163485 - MOHAN; Raju ; et al. | 2021-06-03 |
| Tyk2 Pseudokinase Ligands App 20210139486 - MOHAN; Raju ; et al. | 2021-05-13 |
| Ror-gamma Modulators App 20210069182 - MOHAN; Raju ; et al. | 2021-03-11 |
| Bicyclic Ror-gamma Modulators App 20210053987 - MOHAN; Raju ; et al. | 2021-02-25 |
| Spirocyclic Ror-gamma Modulators App 20210053976 - MOHAN; Raju ; et al. | 2021-02-25 |
| Jak Inhibitors App 20210040100 - MOHAN; Raju ; et al. | 2021-02-11 |
| Substituted piperazines as ROR-gamma modulators Grant 10,905,687 - Mohan , et al. February 2, 2 | 2021-02-02 |
| Jak Inhibitors App 20200369669 - MOHAN; Raju ; et al. | 2020-11-26 |
| Heterocyclic Compounds For The Treatment Of Disease App 20200325135 - MOHAN; Raju ; et al. | 2020-10-15 |
| Heterocyclic compounds for the treatment of disease Grant 10,683,291 - Mohan , et al. | 2020-06-16 |
| Prodrugs for the Treatment of Disease App 20200071327 - MOHAN; Raju ; et al. | 2020-03-05 |
| Ror-gamma Modulators App 20190269674 - Mohan; Raju ; et al. | 2019-09-05 |
| Heterocyclic Compounds For The Treatment Of Disease App 20190241556 - MOHAN; Raju ; et al. | 2019-08-08 |
| 1-phenylpyrrole derivatives Grant 8,642,640 - Nuss , et al. February 4, 2 | 2014-02-04 |
| Atropisomers of (hydroxyalkyl) pyrrole derivatives Grant 8,487,117 - Nuss , et al. July 16, 2 | 2013-07-16 |
| Pyrimidine derivatives as kinase modulators and method of use Grant 8,211,929 - Chen , et al. July 3, 2 | 2012-07-03 |
| 1-Phenylpyrrole Derivatives App 20110263544 - Nuss; John ; et al. | 2011-10-27 |
| Atropisomers of (Hydroxyalkyl) Pyrrole Derivatives App 20110263673 - Nuss; John ; et al. | 2011-10-27 |
| [1H-pyrazolo[3, 4-D]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-theoronine kinase modulators (P70s6k, Atk1 and Atk2) for the treatment of immunological, inflammatory and proliferative diseases Grant 7,994,172 - Rice , et al. August 9, 2 | 2011-08-09 |
| Pyrimidine Derivatives As Kinase Modulators and Method of Use App 20080249079 - Chen; Jeff ; et al. | 2008-10-09 |
| [1H-Pyrazolo[3, 4-D]Pyrimidin-4-Yl]-Piperidine or -Piperazine Compounds as Serine-Theoronine Kinase Modulators (P70s6k, Atk1 and Atk2) for the Treatment of Immunological, Inflammatory and Proliferative Diseases App 20080188482 - Rice; Ken ; et al. | 2008-08-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 